GTx, Inc. (Nasdaq: GTXI) announced today a webcast discussing Capesaris®(GTx-758) and it’s potential role in the treatment of advanced prostate cancer in men is scheduled for Friday, February 15 th 2013, from 9:00am – 10:00am Eastern Time. The presentations will be conducted by an expert faculty panel to include: Phillip Kantoff, MD, Dana-Farber Cancer Institute/Brigham and Women’s Hospital; Thomas Flaig, MD, University of Colorado School of Medicine; and Evan Yu, MD, Fred Hutchinson Cancer Research Center.Register for the live webcast at ( http://www.media-server.com/m/p/tseh66fk).
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts